A novel dominant-negative mutation of the hepatocyte nuclear factor-1α gene in Japanese early-onset type 2 diabetes

Hormone and Metabolic Research

Volumn 32, Issue 9, 2000, Pages 373-377

  Tanaka, S ^a   Kobayashi, T ^a   Tomura, H ^b   Okubo, M ^a   Nakanishi, K ^a   Takeda, J ^b   Murase, T ^a  

^a TORANOMON HOSPITAL   (Japan)

^b GUNMA UNIVERSITY   (Japan)

Author keywords

Frameshift Mutation; Insulin Secretion; Luciferase Assay; Maturity Onset Diabetes of the Young; Transcription Factor

Indexed keywords

INSULIN; LUCIFERASE; MUTANT PROTEIN; NUCLEAR FACTOR I; TRANSCRIPTION FACTOR;

ADULT; AMINO ACID SUBSTITUTION; AMINO TERMINAL SEQUENCE; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DOMINANT GENE; FEMALE; FRAMESHIFT MUTATION; GENE DELETION; GENE INSERTION; GENE MUTATION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; INSULIN RELEASE; JAPAN; JUVENILE DIABETES MELLITUS; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; PROTEIN DEFECT; RELATIVE; TRANSACTIVATION;

EID: 0033798194     PISSN: 00185043     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-978656     Document Type: Article

References (30)

1. Mutations in the hepatocyte nuclear factor-1α gene in maturity-onset diabetes of the young (MODY3)
2. Maturity-onset diabetes of the young (MODY)
3. Mutations in the hepatocyte nuclear factor-1α gene in MODY and early-onset NIDDM: Evidence for a mutational hotspot in exon 4
4. Hepatocyte nuclear factor-1α coding mutations are an uncommon contributor to early-onset type 2 diabetes in Ashkenazi Jews
5. Mutations in the hepatocyte nuclear factor-1α gene (MODY3) are not a major cause of early-onset non-insulin-dependent (type 2) diabetes mellitus in Japanese
6. Mutations in the hepatocyte nuclear factor-1α/MODY3 gene in Japanese subjects with early- and late-onset NIDDM
7. Mutation P291fsinsC in the transcription factor hepatocyte nuclear factor-1α is dominant negative
8. Anatomy of a homeoprotein revealed by the analysis of human MODY3 mutations
9. Identification of mutations in the hepatocyte nuclear factor-1α gene in Japanese subjects with early-onset NIDDM and functional analysis of the mutant proteins
10. Three new mutations in the hepatocyte nuclear factor-1α gene in Japanese subjects with diabetes mellitus: Clinical features and functional characterization
11. Identification and functional analysis of mutations in the hepatocyte nuclear factor-1α gene in anti-islet autoantibody-negative Japanese patients with type 1 diabetes
12. Identification of seven novel nucleotide variants in the hepatocyte nuclear factor-1α (TCF1) promoter region in MODY patients
13. Structure/function studies of hepatocyte nuclear factor-1α, a diabetes-associated transcription factor
14. Human insulin gene is a target gene of hepatocyte nuclear factor-1α (HNF-1α) and HNF-1β
15. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: Diagnosis and classification of diabetes mellitus provisional report of a WHO consultation
16. Small doses of subcutaneous insulin as a strategy for preventing slowly progressive β-cell failure in islet cell antibody-positive patients with clinical features of NIDDM
17. Organization of the human GLUT2 (pancreatic β-cell and hepatocyte) glucose transporter gene
18. Establishment of a pancreatic β cell line that retains glucose-inducible insulin secretion: Special reference to expression of glucose transporter isoforms
19. Mutations in the hepatocyte nuclear factor-1α gene are a common cause of maturity-onset diabetes of the young in the U.K.
20. Novel mutations and a mutational hotspot in the MODY3 gene
21. Identification of mutations in the hepatocyte nuclear factor (HNF)-1α gene in Japanese subjects with IDDM
22. Transcription factors and liver-specific genes
23. A myosin-like dimerization helix and an extra-large homeodomain are essential elements of the tripartite DNA binding structure of LFB1
24. Mutation screening in 18 Caucasian families suggest the existence of other MODY genes
25. The transcription factor HNF1 acts with C/EBP α to synergistically activate the human albumin promoter through a novel domain
26. Altered insulin secretory responses to glucose in diabetic and nondiabetic subjects with mutations in the diabetes susceptibility gene MODY3 on chromosome 12
27. Novel MODY3 mutations in the hepatocyte nuclear factor-1 α gene: Evidence for a hyperexcitability of pancreatic β-cells to intravenous secretagogues in a glucose-tolerant carrier of a P447L mutation
28. Characterization of the MODY3 phenotype. Early-onset diabetes caused by an insulin secretion defect
29. A novel missense mutation in the homeodomain of the hepatocyte nuclear factor-1α/maturity-onset diabetes of the young 3 in a Japanese early-onset type 2 diabetic patient and time-course of glucose-stimulated insulin secretion
30. Insulin secretion and insulin sensitivity in diabetic and non-diabetic subjects with hepatic nuclear factor-1α (maturity-onset diabetes of the young-3) mutations